Higher-dose glutathione therapy for Parkinson's disease in Japan: is it really safe?
Naito
Yutaka
Y
Matsuo
Ko
K
Kokubo
Yasumasa
Y
Narita
Yugo
Y
Tomimoto
Hidekazu
H
D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005978:Glutathione / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007564:Japan; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D005978:Glutathione